NO20020523L - Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger - Google Patents

Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger

Info

Publication number
NO20020523L
NO20020523L NO20020523A NO20020523A NO20020523L NO 20020523 L NO20020523 L NO 20020523L NO 20020523 A NO20020523 A NO 20020523A NO 20020523 A NO20020523 A NO 20020523A NO 20020523 L NO20020523 L NO 20020523L
Authority
NO
Norway
Prior art keywords
compounds
glaucoma
treatment
further provides
phosphinicoprostaglandin
Prior art date
Application number
NO20020523A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020523D0 (no
Inventor
Mitchell Anthony Delong
John August Wos
Biswanath De
Frank Hallock Ebetino
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20020523D0 publication Critical patent/NO20020523D0/no
Publication of NO20020523L publication Critical patent/NO20020523L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/303—Cycloaliphatic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020523A 1999-08-04 2002-02-01 Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger NO20020523L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14713299P 1999-08-04 1999-08-04
PCT/US2000/020851 WO2001010873A1 (en) 1999-08-04 2000-08-01 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs

Publications (2)

Publication Number Publication Date
NO20020523D0 NO20020523D0 (no) 2002-02-01
NO20020523L true NO20020523L (no) 2002-04-02

Family

ID=22520396

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020523A NO20020523L (no) 1999-08-04 2002-02-01 Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger

Country Status (12)

Country Link
US (1) US6372730B1 (es)
EP (1) EP1202999B1 (es)
JP (1) JP4846150B2 (es)
AT (1) ATE243215T1 (es)
AU (1) AU776375B2 (es)
CA (1) CA2380326C (es)
CO (1) CO5180630A1 (es)
DE (1) DE60003435T2 (es)
ES (1) ES2202156T3 (es)
IL (1) IL147771A0 (es)
NO (1) NO20020523L (es)
WO (1) WO2001010873A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL350917A1 (en) 1999-03-05 2003-02-10 Procter & Gamble C16 unsaturated fp-selective prostaglandins analogs
US6884858B2 (en) 1999-10-19 2005-04-26 Texas Petrochemicals Lp Process for preparing polyolefin products
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20060135609A1 (en) * 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US8916206B2 (en) 2005-12-26 2014-12-23 Ltt Bio-Pharma Co., Ltd. Nanoparticles containing water-soluble non-peptide low-molecular weight drug
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
WO2008139804A1 (ja) * 2007-05-14 2008-11-20 Ltt Bio-Pharma Co., Ltd. 徐放性の陰荷電基を持つ低分子薬物含有ナノ粒子
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
WO2010058669A1 (ja) * 2008-11-18 2010-05-27 株式会社Ｌｔｔバイオファーマ 新規プロスタグランジンｅ１誘導体及びそれを封入するナノ粒子
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN105319283A (zh) * 2014-07-17 2016-02-10 上海市农药研究所 检测三联吡啶含量的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171331A (en) 1978-06-05 1979-10-16 Miles Laboratories, Inc. 1 And 2-substituted analogues of certain prostaglandins
US5312832A (en) 1991-05-17 1994-05-17 Allergan, Inc. Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US5658897A (en) * 1996-04-08 1997-08-19 Allergan Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
US6107338A (en) * 1997-09-09 2000-08-22 The Procter & Gamble Company Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
NZ503735A (en) * 1997-09-09 2001-05-25 Procter & Gamble Aromatic C16-20-substituted tetrahydro prostaglandin F analogues useful as FP agonists
CN1269784A (zh) * 1997-09-09 2000-10-11 普罗克特和甘保尔公司 用作fp激活剂的芳香族c16－c20－取代四氢前列腺素
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease

Also Published As

Publication number Publication date
ES2202156T3 (es) 2004-04-01
AU776375B2 (en) 2004-09-09
CO5180630A1 (es) 2002-07-30
IL147771A0 (en) 2002-08-14
DE60003435T2 (de) 2004-05-19
JP4846150B2 (ja) 2011-12-28
EP1202999A1 (en) 2002-05-08
DE60003435D1 (de) 2003-07-24
CA2380326C (en) 2008-03-18
WO2001010873A1 (en) 2001-02-15
AU6393300A (en) 2001-03-05
NO20020523D0 (no) 2002-02-01
ATE243215T1 (de) 2003-07-15
JP2003506454A (ja) 2003-02-18
EP1202999B1 (en) 2003-06-18
CA2380326A1 (en) 2001-02-15
US6372730B1 (en) 2002-04-16

Similar Documents

Publication Publication Date Title
CA2303801A1 (en) Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
CA2303764A1 (en) Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
NO20020523L (no) Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger
CA2303763A1 (en) Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
HK1076107A1 (en) Pyrrolidine derivatives as oxytocin antagonists
CA2364944A1 (en) C16 unsaturated fp-selective prostaglandins analogs
BR0008776A (pt) Análogos de prostaglandinas fp-seletivosinsaturados c16
BR0008716A (pt) Inibidores de metaloprotease contendo alquenil ou alquinil
CA2324343A1 (en) C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
WO2001070693A3 (en) Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
CA2324590A1 (en) C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
CO5271694A1 (es) Inhibidores beta di-sustituidos de las metaloproteasas, composiciones farmaceuticas que los contienen y procedimientos para su aplicacion
EA200101109A1 (ru) Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application